Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for α2 chain of laminin)

被引:97
作者
Allamand, V [1 ]
Guicheney, P [1 ]
机构
[1] Grp Hosp Pitie Salpetriere, INSERM U523, Inst Myol, F-75651 Paris 13, France
关键词
congenital muscular dystrophy; laminin; merosin-deficiency; extracellular matrix; skeletal muscle;
D O I
10.1038/sj.ejhg.5200743
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Congenital muscular dystrophies (CMDs) are a highly heterogeneous group of neuromuscular disorders. A subgroup displays a specific deficiency in a protein of the extracellular matrix, the alpha2 chain of laminin-2 (merosin). A number of mutations in the gene encoding this protein have been identified in patients who present with a severe phenotype and white matter changes.
引用
收藏
页码:91 / 94
页数:4
相关论文
共 12 条
  • [1] Animal models for muscular dystrophy: valuable tools for the development of therapies
    Allamand, V
    Campbell, KP
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (16) : 2459 - 2467
  • [2] Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan
    Brockington, M
    Blake, DJ
    Prandini, P
    Brown, SC
    Torelli, S
    Benson, MA
    Ponting, CP
    Estournet, B
    Romero, NB
    Mercuri, E
    Voit, T
    Sewry, CA
    Guicheney, P
    Muntoni, F
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (06) : 1198 - 1209
  • [3] PCR based mutation screening of the laminin α2 chain gene (LAMA2):: application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy
    Guicheney, P
    Vignier, N
    Zhang, X
    He, Y
    Cruaud, C
    Frey, V
    Helbling-Leclerc, A
    Richard, P
    Estournet, B
    Merlini, L
    Topaloglu, H
    Mora, M
    Harpey, JP
    Haenggeli, CA
    Barois, A
    Hainque, B
    Schwartz, K
    Tome, FMS
    Fardeau, M
    Tryggvason, K
    [J]. JOURNAL OF MEDICAL GENETICS, 1998, 35 (03) : 211 - 217
  • [4] Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy
    Hayashi, YK
    Tezak, Z
    Momoi, T
    Nonaka, I
    Garcia, CA
    Hoffman, EP
    Arahata, K
    [J]. NEUROMUSCULAR DISORDERS, 2001, 11 (04) : 350 - 359
  • [5] Congenital muscular dystrophy with primary partial laminin α2 chain deficiency:: Molecular study
    He, Y
    Jones, KJ
    Vignier, N
    Morgan, G
    Chevallay, M
    Barois, A
    Estournet-Mathiaud, B
    Hori, H
    Mizuta, T
    Tomé, FMS
    North, KN
    Guicheney, P
    [J]. NEUROLOGY, 2001, 57 (07) : 1319 - 1322
  • [6] HEIBLINGLECLERC A, 2000, METHODS MOL MED, P199
  • [7] Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO
  • [8] 2-Q
  • [9] Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy
    Mostacciuolo, ML
    Miorin, M
    Martinello, F
    Angelini, C
    Perini, P
    Trevisan, CP
    [J]. HUMAN GENETICS, 1996, 97 (03) : 277 - 279
  • [10] MUNTONI F, 2001, 85 ENMC INT WORKSH C, V12, P69